AlphaQuest LLC Makes New Investment in Tactile Systems Technology, Inc. (NASDAQ:TCMD)

AlphaQuest LLC acquired a new position in Tactile Systems Technology, Inc. (NASDAQ:TCMD) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 9,247 shares of the company’s stock, valued at approximately $158,000.

Other hedge funds also recently modified their holdings of the company. Jones Financial Companies Lllp bought a new stake in shares of Tactile Systems Technology in the 4th quarter worth approximately $39,000. Retireful LLC bought a new stake in shares of Tactile Systems Technology in the 4th quarter worth approximately $173,000. XTX Topco Ltd acquired a new position in shares of Tactile Systems Technology in the 3rd quarter worth approximately $163,000. SG Americas Securities LLC raised its holdings in shares of Tactile Systems Technology by 12.7% in the 4th quarter. SG Americas Securities LLC now owns 12,032 shares of the company’s stock worth $206,000 after buying an additional 1,354 shares in the last quarter. Finally, Victory Capital Management Inc. acquired a new position in shares of Tactile Systems Technology in the 3rd quarter worth approximately $180,000. Institutional investors own 83.43% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on TCMD shares. B. Riley cut Tactile Systems Technology from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $23.00 to $18.00 in a report on Wednesday, February 19th. StockNews.com cut Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a report on Thursday, January 16th.

Tactile Systems Technology Trading Up 2.8 %

TCMD stock opened at $13.53 on Tuesday. The business has a fifty day moving average price of $16.20 and a 200 day moving average price of $15.82. Tactile Systems Technology, Inc. has a fifty-two week low of $11.12 and a fifty-two week high of $21.10. The stock has a market capitalization of $319.11 million, a price-to-earnings ratio of 19.33 and a beta of 1.24. The company has a debt-to-equity ratio of 0.11, a current ratio of 4.36 and a quick ratio of 3.80.

Tactile Systems Technology (NASDAQ:TCMD) last released its quarterly earnings results on Tuesday, February 18th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.09. Tactile Systems Technology had a return on equity of 9.37% and a net margin of 5.79%. The firm had revenue of $85.59 million during the quarter, compared to analysts’ expectations of $85.39 million. Analysts expect that Tactile Systems Technology, Inc. will post 0.7 EPS for the current fiscal year.

Insider Activity at Tactile Systems Technology

In other Tactile Systems Technology news, VP Kristie Burns sold 4,830 shares of the stock in a transaction on Monday, February 24th. The stock was sold at an average price of $14.65, for a total value of $70,759.50. Following the transaction, the vice president now directly owns 84,008 shares in the company, valued at approximately $1,230,717.20. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Daniel L. Reuvers sold 10,938 shares of the stock in a transaction on Monday, February 24th. The shares were sold at an average price of $14.55, for a total value of $159,147.90. Following the completion of the transaction, the director now owns 242,942 shares in the company, valued at $3,534,806.10. The trade was a 4.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 19,546 shares of company stock valued at $285,444 in the last three months. Corporate insiders own 0.96% of the company’s stock.

Tactile Systems Technology Profile

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.